Cell Banking Outsourcing research
Cell Banking Outsourcing research

Cell Banking Outsourcing Comprehensive Study by Type (Master Cell Banking, Working Cell Banking, Viral Cell Banking), Phase (Preparation, Testing, Characterization), Bank Storage (Master Cell Bank Storage, Working Cell Bank Storage, Cell Storage Stability Testing), Cell Type (Stem Cell Banking, Non-Stem Cell Banking) Players and Region - Global Market Outlook to 2027

Cell Banking Outsourcing Market Segmented into XX Submarkets. | Forecast Years: 2022- 2027  

Apr 2022 Edition 242 Pages 170 Tables & Figures
  • Summary
  • Market Segments
  • Table of Content
  • List of Tables & Figures
  • Companies Mentioned
Cell Banking Outsourcing Market Scope
Cell banking is the process of reproducing and conserving cells for future use. These cell samples can be stored indefinitely for use in research and surgical tissue regeneration. Cryoprotection agents such as DMSO (10%) solution are used to freeze cells in cryovials at -196 degrees Celsius. The most common application of cell banking is in stem cell research and therapy. Cell banks can be divided into two types: master cell banks and operational cell banks. Expanding master cell banks create working cell banks. Master cell banks have pure cells from which cells are replicated, whereas working cell banks have thawed cells that are replicated in cell culture.

The Cell Banking Outsourcing market study is segmented by Type (Master Cell Banking, Working Cell Banking and Viral Cell Banking) and major geographies with country level break-up.

The cell banking outsourcing market is characterized by the presence of several global, regional, and local vendors catering to the demand created by research scientists and pharmaceutical and biotechnology companies. The growing need for mobile banking outsourcing is propelling the market forward. In this highly competitive industry, players compete and collaborate to gain a considerable market share. In February 2021, Catalent (US) and Trizell GmbH (Germany) signed an agreement to facilitate the manufacturing of Trizell's Phase 1 cell therapy for the treatment of micro-and macroangiopathies. The top firms have developed strategic alliances and joint ventures to maintain their market positions.

BioReliance (United States), Global Stem Inc (United States), BSL Disservice (United States), Clean cells (France), Charles River Laboratories Lonza (United States), Toxikon Corporation (United States), Cryobanks International (India), Wuxi Apptec (China), Reliance Life Sciences (India) and BioOutsource (India) are some of the key players that are part of study coverage. Additionally, the Players which are also part of the research are CordLife (Singapore), PX’Therapeutics SA (France) and SGS Life Sciences (India).

About Approach
The research aims to propose a patent-based approach in searching for potential technology partners as a supporting tool for enabling open innovation. The study also proposes a systematic searching process of technology partners as a
preliminary step to select the emerging and key players that are involved in implementing market estimations. While patent analysis is employed to overcome the aforementioned data- and process-related limitations, as expenses occurred in that technology allows us to estimate the market size by evolving segments as target market from total available market.

Segmentation Overview
AMA Research has segmented the market of Global Cell Banking Outsourcing market by Type, Application and Region.

On the basis of geography, the market of Cell Banking Outsourcing has been segmented into South America (Brazil, Argentina, Rest of South America), Asia Pacific (China, Japan, India, South Korea, Taiwan, Australia, Rest of Asia-Pacific), Europe (Germany, France, Italy, United Kingdom, Netherlands, Rest of Europe), MEA (Middle East, Africa), North America (United States, Canada, Mexico).

In Feb 2021, CiRC Biosciences, a cell therapy firm founded by Paragon Biosciences in the United States, is researching remedies for diseases with a high unmet need, with an initial focus on eye disorders. and In April 2020, Hope Biosciences (US), a clinical-stage startup focused on cell-based treatments, has acquired FDA permission for Phase II clinical research testing the efficacy and safety of its mesenchymal stem cells in providing immunological support against COVID-19.


Market Trend
  • Rapid Advancement in the Banking Sector

Market Drivers
  • Increasing Awareness Regarding Stem Cell Therapies
  • Increasing Adoption of Collaboration and Acquisition Strategies by Market Key Players
  • Increasing Stem Cell Research and Development Endeavours in the Production of Novel Therapeutic Options for Rare Diseases

Opportunities
  • Development of Cell Banks in Developing Countries
  • Increasing Funding and Government Rules
  • Innovating New Products and Services in Developing Countries

Restraints
  • High Cost Associated With Storing Cells in Cell Banks
  • High Capital Investment

Challenges
  • Strict Government Rules and Increased competition in the market


Key Target Audience
Industry Association, Downstream Vendors, Marketing & Consulting firms, Venture Capitalists, Government & Regulatory Bodies and Investors

Frequently Asked Questions (FAQ):

1. Is it possible to have certain customization in the study?
The Study can be customized to meet your requirements. Please connect with our representative, who will ensure you get a study that suits your business objectives.

2. How big is the Cell Banking Outsourcing Market?
Yes, the study does represent market size by key business segment, application/end users and major geographies forecasted till 2027.

Report Objectives / Segmentation Covered
By Type
  • Master Cell Banking
  • Working Cell Banking
  • Viral Cell Banking
By Phase
  • Preparation
  • Testing
  • Characterization

By Bank Storage
  • Master Cell Bank Storage
  • Working Cell Bank Storage
  • Cell Storage Stability Testing

By Cell Type
  • Stem Cell Banking
  • Non-Stem Cell Banking

By Regions
  • South America
    • Brazil
    • Argentina
    • Rest of South America
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Taiwan
    • Australia
    • Rest of Asia-Pacific
  • Europe
    • Germany
    • France
    • Italy
    • United Kingdom
    • Netherlands
    • Rest of Europe
  • MEA
    • Middle East
    • Africa
  • North America
    • United States
    • Canada
    • Mexico
  • 1. Market Overview
    • 1.1. Introduction
    • 1.2. Scope/Objective of the Study
      • 1.2.1. Research Objective
  • 2. Executive Summary
    • 2.1. Introduction
  • 3. Market Dynamics
    • 3.1. Introduction
    • 3.2. Market Drivers
      • 3.2.1. Increasing Awareness Regarding Stem Cell Therapies
      • 3.2.2. Increasing Adoption of Collaboration and Acquisition Strategies by Market Key Players
      • 3.2.3. Increasing Stem Cell Research and Development Endeavours in the Production of Novel Therapeutic Options for Rare Diseases
    • 3.3. Market Challenges
      • 3.3.1. Strict Government Rules and Increased competition in the market
    • 3.4. Market Trends
      • 3.4.1. Rapid Advancement in the Banking Sector
  • 4. Market Factor Analysis
    • 4.1. Porters Five Forces
    • 4.2. Supply/Value Chain
    • 4.3. PESTEL analysis
    • 4.4. Market Entropy
    • 4.5. Patent/Trademark Analysis
  • 5. Global Cell Banking Outsourcing, by Type, Phase, Bank Storage, Cell Type and Region (value and price ) (2016-2021)
    • 5.1. Introduction
    • 5.2. Global Cell Banking Outsourcing (Value)
      • 5.2.1. Global Cell Banking Outsourcing by: Type (Value)
        • 5.2.1.1. Master Cell Banking
        • 5.2.1.2. Working Cell Banking
        • 5.2.1.3. Viral Cell Banking
      • 5.2.2. Global Cell Banking Outsourcing by: Phase (Value)
        • 5.2.2.1. Preparation
        • 5.2.2.2. Testing
        • 5.2.2.3. Characterization
      • 5.2.3. Global Cell Banking Outsourcing by: Bank Storage (Value)
        • 5.2.3.1. Master Cell Bank Storage
        • 5.2.3.2. Working Cell Bank Storage
        • 5.2.3.3. Cell Storage Stability Testing
      • 5.2.4. Global Cell Banking Outsourcing by: Cell Type (Value)
        • 5.2.4.1. Stem Cell Banking
        • 5.2.4.2. Non-Stem Cell Banking
      • 5.2.5. Global Cell Banking Outsourcing Region
        • 5.2.5.1. South America
          • 5.2.5.1.1. Brazil
          • 5.2.5.1.2. Argentina
          • 5.2.5.1.3. Rest of South America
        • 5.2.5.2. Asia Pacific
          • 5.2.5.2.1. China
          • 5.2.5.2.2. Japan
          • 5.2.5.2.3. India
          • 5.2.5.2.4. South Korea
          • 5.2.5.2.5. Taiwan
          • 5.2.5.2.6. Australia
          • 5.2.5.2.7. Rest of Asia-Pacific
        • 5.2.5.3. Europe
          • 5.2.5.3.1. Germany
          • 5.2.5.3.2. France
          • 5.2.5.3.3. Italy
          • 5.2.5.3.4. United Kingdom
          • 5.2.5.3.5. Netherlands
          • 5.2.5.3.6. Rest of Europe
        • 5.2.5.4. MEA
          • 5.2.5.4.1. Middle East
          • 5.2.5.4.2. Africa
        • 5.2.5.5. North America
          • 5.2.5.5.1. United States
          • 5.2.5.5.2. Canada
          • 5.2.5.5.3. Mexico
    • 5.3. Global Cell Banking Outsourcing (Price)
      • 5.3.1. Global Cell Banking Outsourcing by: Type (Price)
  • 6. Cell Banking Outsourcing: Manufacturers/Players Analysis
    • 6.1. Competitive Landscape
      • 6.1.1. Market Share Analysis
        • 6.1.1.1. Top 3
        • 6.1.1.2. Top 5
    • 6.2. Peer Group Analysis (2021)
    • 6.3. BCG Matrix
    • 6.4. Company Profile
      • 6.4.1. BioReliance (United States)
        • 6.4.1.1. Business Overview
        • 6.4.1.2. Products/Services Offerings
        • 6.4.1.3. Financial Analysis
        • 6.4.1.4. SWOT Analysis
      • 6.4.2. Global Stem Inc (United States)
        • 6.4.2.1. Business Overview
        • 6.4.2.2. Products/Services Offerings
        • 6.4.2.3. Financial Analysis
        • 6.4.2.4. SWOT Analysis
      • 6.4.3. BSL Disservice (United States)
        • 6.4.3.1. Business Overview
        • 6.4.3.2. Products/Services Offerings
        • 6.4.3.3. Financial Analysis
        • 6.4.3.4. SWOT Analysis
      • 6.4.4. Clean cells (France)
        • 6.4.4.1. Business Overview
        • 6.4.4.2. Products/Services Offerings
        • 6.4.4.3. Financial Analysis
        • 6.4.4.4. SWOT Analysis
      • 6.4.5. Charles River Laboratories Lonza (United States)
        • 6.4.5.1. Business Overview
        • 6.4.5.2. Products/Services Offerings
        • 6.4.5.3. Financial Analysis
        • 6.4.5.4. SWOT Analysis
      • 6.4.6. Toxikon Corporation (United States)
        • 6.4.6.1. Business Overview
        • 6.4.6.2. Products/Services Offerings
        • 6.4.6.3. Financial Analysis
        • 6.4.6.4. SWOT Analysis
      • 6.4.7. Cryobanks International (India)
        • 6.4.7.1. Business Overview
        • 6.4.7.2. Products/Services Offerings
        • 6.4.7.3. Financial Analysis
        • 6.4.7.4. SWOT Analysis
      • 6.4.8. Wuxi Apptec (China)
        • 6.4.8.1. Business Overview
        • 6.4.8.2. Products/Services Offerings
        • 6.4.8.3. Financial Analysis
        • 6.4.8.4. SWOT Analysis
      • 6.4.9. Reliance Life Sciences (India)
        • 6.4.9.1. Business Overview
        • 6.4.9.2. Products/Services Offerings
        • 6.4.9.3. Financial Analysis
        • 6.4.9.4. SWOT Analysis
      • 6.4.10. BioOutsource (India)
        • 6.4.10.1. Business Overview
        • 6.4.10.2. Products/Services Offerings
        • 6.4.10.3. Financial Analysis
        • 6.4.10.4. SWOT Analysis
  • 7. Global Cell Banking Outsourcing Sale, by Type, Phase, Bank Storage, Cell Type and Region (value and price ) (2022-2027)
    • 7.1. Introduction
    • 7.2. Global Cell Banking Outsourcing (Value)
      • 7.2.1. Global Cell Banking Outsourcing by: Type (Value)
        • 7.2.1.1. Master Cell Banking
        • 7.2.1.2. Working Cell Banking
        • 7.2.1.3. Viral Cell Banking
      • 7.2.2. Global Cell Banking Outsourcing by: Phase (Value)
        • 7.2.2.1. Preparation
        • 7.2.2.2. Testing
        • 7.2.2.3. Characterization
      • 7.2.3. Global Cell Banking Outsourcing by: Bank Storage (Value)
        • 7.2.3.1. Master Cell Bank Storage
        • 7.2.3.2. Working Cell Bank Storage
        • 7.2.3.3. Cell Storage Stability Testing
      • 7.2.4. Global Cell Banking Outsourcing by: Cell Type (Value)
        • 7.2.4.1. Stem Cell Banking
        • 7.2.4.2. Non-Stem Cell Banking
      • 7.2.5. Global Cell Banking Outsourcing Region
        • 7.2.5.1. South America
          • 7.2.5.1.1. Brazil
          • 7.2.5.1.2. Argentina
          • 7.2.5.1.3. Rest of South America
        • 7.2.5.2. Asia Pacific
          • 7.2.5.2.1. China
          • 7.2.5.2.2. Japan
          • 7.2.5.2.3. India
          • 7.2.5.2.4. South Korea
          • 7.2.5.2.5. Taiwan
          • 7.2.5.2.6. Australia
          • 7.2.5.2.7. Rest of Asia-Pacific
        • 7.2.5.3. Europe
          • 7.2.5.3.1. Germany
          • 7.2.5.3.2. France
          • 7.2.5.3.3. Italy
          • 7.2.5.3.4. United Kingdom
          • 7.2.5.3.5. Netherlands
          • 7.2.5.3.6. Rest of Europe
        • 7.2.5.4. MEA
          • 7.2.5.4.1. Middle East
          • 7.2.5.4.2. Africa
        • 7.2.5.5. North America
          • 7.2.5.5.1. United States
          • 7.2.5.5.2. Canada
          • 7.2.5.5.3. Mexico
    • 7.3. Global Cell Banking Outsourcing (Price)
      • 7.3.1. Global Cell Banking Outsourcing by: Type (Price)
  • 8. Appendix
    • 8.1. Acronyms
  • 9. Methodology and Data Source
    • 9.1. Methodology/Research Approach
      • 9.1.1. Research Programs/Design
      • 9.1.2. Market Size Estimation
      • 9.1.3. Market Breakdown and Data Triangulation
    • 9.2. Data Source
      • 9.2.1. Secondary Sources
      • 9.2.2. Primary Sources
    • 9.3. Disclaimer
List of Tables
  • Table 1. Cell Banking Outsourcing: by Type(USD Million)
  • Table 2. Cell Banking Outsourcing Master Cell Banking , by Region USD Million (2016-2021)
  • Table 3. Cell Banking Outsourcing Working Cell Banking , by Region USD Million (2016-2021)
  • Table 4. Cell Banking Outsourcing Viral Cell Banking , by Region USD Million (2016-2021)
  • Table 5. Cell Banking Outsourcing: by Phase(USD Million)
  • Table 6. Cell Banking Outsourcing Preparation , by Region USD Million (2016-2021)
  • Table 7. Cell Banking Outsourcing Testing , by Region USD Million (2016-2021)
  • Table 8. Cell Banking Outsourcing Characterization , by Region USD Million (2016-2021)
  • Table 9. Cell Banking Outsourcing: by Bank Storage(USD Million)
  • Table 10. Cell Banking Outsourcing Master Cell Bank Storage , by Region USD Million (2016-2021)
  • Table 11. Cell Banking Outsourcing Working Cell Bank Storage , by Region USD Million (2016-2021)
  • Table 12. Cell Banking Outsourcing Cell Storage Stability Testing , by Region USD Million (2016-2021)
  • Table 13. Cell Banking Outsourcing: by Cell Type(USD Million)
  • Table 14. Cell Banking Outsourcing Stem Cell Banking , by Region USD Million (2016-2021)
  • Table 15. Cell Banking Outsourcing Non-Stem Cell Banking , by Region USD Million (2016-2021)
  • Table 16. South America Cell Banking Outsourcing, by Country USD Million (2016-2021)
  • Table 17. South America Cell Banking Outsourcing, by Type USD Million (2016-2021)
  • Table 18. South America Cell Banking Outsourcing, by Phase USD Million (2016-2021)
  • Table 19. South America Cell Banking Outsourcing, by Bank Storage USD Million (2016-2021)
  • Table 20. South America Cell Banking Outsourcing, by Cell Type USD Million (2016-2021)
  • Table 21. Brazil Cell Banking Outsourcing, by Type USD Million (2016-2021)
  • Table 22. Brazil Cell Banking Outsourcing, by Phase USD Million (2016-2021)
  • Table 23. Brazil Cell Banking Outsourcing, by Bank Storage USD Million (2016-2021)
  • Table 24. Brazil Cell Banking Outsourcing, by Cell Type USD Million (2016-2021)
  • Table 25. Argentina Cell Banking Outsourcing, by Type USD Million (2016-2021)
  • Table 26. Argentina Cell Banking Outsourcing, by Phase USD Million (2016-2021)
  • Table 27. Argentina Cell Banking Outsourcing, by Bank Storage USD Million (2016-2021)
  • Table 28. Argentina Cell Banking Outsourcing, by Cell Type USD Million (2016-2021)
  • Table 29. Rest of South America Cell Banking Outsourcing, by Type USD Million (2016-2021)
  • Table 30. Rest of South America Cell Banking Outsourcing, by Phase USD Million (2016-2021)
  • Table 31. Rest of South America Cell Banking Outsourcing, by Bank Storage USD Million (2016-2021)
  • Table 32. Rest of South America Cell Banking Outsourcing, by Cell Type USD Million (2016-2021)
  • Table 33. Asia Pacific Cell Banking Outsourcing, by Country USD Million (2016-2021)
  • Table 34. Asia Pacific Cell Banking Outsourcing, by Type USD Million (2016-2021)
  • Table 35. Asia Pacific Cell Banking Outsourcing, by Phase USD Million (2016-2021)
  • Table 36. Asia Pacific Cell Banking Outsourcing, by Bank Storage USD Million (2016-2021)
  • Table 37. Asia Pacific Cell Banking Outsourcing, by Cell Type USD Million (2016-2021)
  • Table 38. China Cell Banking Outsourcing, by Type USD Million (2016-2021)
  • Table 39. China Cell Banking Outsourcing, by Phase USD Million (2016-2021)
  • Table 40. China Cell Banking Outsourcing, by Bank Storage USD Million (2016-2021)
  • Table 41. China Cell Banking Outsourcing, by Cell Type USD Million (2016-2021)
  • Table 42. Japan Cell Banking Outsourcing, by Type USD Million (2016-2021)
  • Table 43. Japan Cell Banking Outsourcing, by Phase USD Million (2016-2021)
  • Table 44. Japan Cell Banking Outsourcing, by Bank Storage USD Million (2016-2021)
  • Table 45. Japan Cell Banking Outsourcing, by Cell Type USD Million (2016-2021)
  • Table 46. India Cell Banking Outsourcing, by Type USD Million (2016-2021)
  • Table 47. India Cell Banking Outsourcing, by Phase USD Million (2016-2021)
  • Table 48. India Cell Banking Outsourcing, by Bank Storage USD Million (2016-2021)
  • Table 49. India Cell Banking Outsourcing, by Cell Type USD Million (2016-2021)
  • Table 50. South Korea Cell Banking Outsourcing, by Type USD Million (2016-2021)
  • Table 51. South Korea Cell Banking Outsourcing, by Phase USD Million (2016-2021)
  • Table 52. South Korea Cell Banking Outsourcing, by Bank Storage USD Million (2016-2021)
  • Table 53. South Korea Cell Banking Outsourcing, by Cell Type USD Million (2016-2021)
  • Table 54. Taiwan Cell Banking Outsourcing, by Type USD Million (2016-2021)
  • Table 55. Taiwan Cell Banking Outsourcing, by Phase USD Million (2016-2021)
  • Table 56. Taiwan Cell Banking Outsourcing, by Bank Storage USD Million (2016-2021)
  • Table 57. Taiwan Cell Banking Outsourcing, by Cell Type USD Million (2016-2021)
  • Table 58. Australia Cell Banking Outsourcing, by Type USD Million (2016-2021)
  • Table 59. Australia Cell Banking Outsourcing, by Phase USD Million (2016-2021)
  • Table 60. Australia Cell Banking Outsourcing, by Bank Storage USD Million (2016-2021)
  • Table 61. Australia Cell Banking Outsourcing, by Cell Type USD Million (2016-2021)
  • Table 62. Rest of Asia-Pacific Cell Banking Outsourcing, by Type USD Million (2016-2021)
  • Table 63. Rest of Asia-Pacific Cell Banking Outsourcing, by Phase USD Million (2016-2021)
  • Table 64. Rest of Asia-Pacific Cell Banking Outsourcing, by Bank Storage USD Million (2016-2021)
  • Table 65. Rest of Asia-Pacific Cell Banking Outsourcing, by Cell Type USD Million (2016-2021)
  • Table 66. Europe Cell Banking Outsourcing, by Country USD Million (2016-2021)
  • Table 67. Europe Cell Banking Outsourcing, by Type USD Million (2016-2021)
  • Table 68. Europe Cell Banking Outsourcing, by Phase USD Million (2016-2021)
  • Table 69. Europe Cell Banking Outsourcing, by Bank Storage USD Million (2016-2021)
  • Table 70. Europe Cell Banking Outsourcing, by Cell Type USD Million (2016-2021)
  • Table 71. Germany Cell Banking Outsourcing, by Type USD Million (2016-2021)
  • Table 72. Germany Cell Banking Outsourcing, by Phase USD Million (2016-2021)
  • Table 73. Germany Cell Banking Outsourcing, by Bank Storage USD Million (2016-2021)
  • Table 74. Germany Cell Banking Outsourcing, by Cell Type USD Million (2016-2021)
  • Table 75. France Cell Banking Outsourcing, by Type USD Million (2016-2021)
  • Table 76. France Cell Banking Outsourcing, by Phase USD Million (2016-2021)
  • Table 77. France Cell Banking Outsourcing, by Bank Storage USD Million (2016-2021)
  • Table 78. France Cell Banking Outsourcing, by Cell Type USD Million (2016-2021)
  • Table 79. Italy Cell Banking Outsourcing, by Type USD Million (2016-2021)
  • Table 80. Italy Cell Banking Outsourcing, by Phase USD Million (2016-2021)
  • Table 81. Italy Cell Banking Outsourcing, by Bank Storage USD Million (2016-2021)
  • Table 82. Italy Cell Banking Outsourcing, by Cell Type USD Million (2016-2021)
  • Table 83. United Kingdom Cell Banking Outsourcing, by Type USD Million (2016-2021)
  • Table 84. United Kingdom Cell Banking Outsourcing, by Phase USD Million (2016-2021)
  • Table 85. United Kingdom Cell Banking Outsourcing, by Bank Storage USD Million (2016-2021)
  • Table 86. United Kingdom Cell Banking Outsourcing, by Cell Type USD Million (2016-2021)
  • Table 87. Netherlands Cell Banking Outsourcing, by Type USD Million (2016-2021)
  • Table 88. Netherlands Cell Banking Outsourcing, by Phase USD Million (2016-2021)
  • Table 89. Netherlands Cell Banking Outsourcing, by Bank Storage USD Million (2016-2021)
  • Table 90. Netherlands Cell Banking Outsourcing, by Cell Type USD Million (2016-2021)
  • Table 91. Rest of Europe Cell Banking Outsourcing, by Type USD Million (2016-2021)
  • Table 92. Rest of Europe Cell Banking Outsourcing, by Phase USD Million (2016-2021)
  • Table 93. Rest of Europe Cell Banking Outsourcing, by Bank Storage USD Million (2016-2021)
  • Table 94. Rest of Europe Cell Banking Outsourcing, by Cell Type USD Million (2016-2021)
  • Table 95. MEA Cell Banking Outsourcing, by Country USD Million (2016-2021)
  • Table 96. MEA Cell Banking Outsourcing, by Type USD Million (2016-2021)
  • Table 97. MEA Cell Banking Outsourcing, by Phase USD Million (2016-2021)
  • Table 98. MEA Cell Banking Outsourcing, by Bank Storage USD Million (2016-2021)
  • Table 99. MEA Cell Banking Outsourcing, by Cell Type USD Million (2016-2021)
  • Table 100. Middle East Cell Banking Outsourcing, by Type USD Million (2016-2021)
  • Table 101. Middle East Cell Banking Outsourcing, by Phase USD Million (2016-2021)
  • Table 102. Middle East Cell Banking Outsourcing, by Bank Storage USD Million (2016-2021)
  • Table 103. Middle East Cell Banking Outsourcing, by Cell Type USD Million (2016-2021)
  • Table 104. Africa Cell Banking Outsourcing, by Type USD Million (2016-2021)
  • Table 105. Africa Cell Banking Outsourcing, by Phase USD Million (2016-2021)
  • Table 106. Africa Cell Banking Outsourcing, by Bank Storage USD Million (2016-2021)
  • Table 107. Africa Cell Banking Outsourcing, by Cell Type USD Million (2016-2021)
  • Table 108. North America Cell Banking Outsourcing, by Country USD Million (2016-2021)
  • Table 109. North America Cell Banking Outsourcing, by Type USD Million (2016-2021)
  • Table 110. North America Cell Banking Outsourcing, by Phase USD Million (2016-2021)
  • Table 111. North America Cell Banking Outsourcing, by Bank Storage USD Million (2016-2021)
  • Table 112. North America Cell Banking Outsourcing, by Cell Type USD Million (2016-2021)
  • Table 113. United States Cell Banking Outsourcing, by Type USD Million (2016-2021)
  • Table 114. United States Cell Banking Outsourcing, by Phase USD Million (2016-2021)
  • Table 115. United States Cell Banking Outsourcing, by Bank Storage USD Million (2016-2021)
  • Table 116. United States Cell Banking Outsourcing, by Cell Type USD Million (2016-2021)
  • Table 117. Canada Cell Banking Outsourcing, by Type USD Million (2016-2021)
  • Table 118. Canada Cell Banking Outsourcing, by Phase USD Million (2016-2021)
  • Table 119. Canada Cell Banking Outsourcing, by Bank Storage USD Million (2016-2021)
  • Table 120. Canada Cell Banking Outsourcing, by Cell Type USD Million (2016-2021)
  • Table 121. Mexico Cell Banking Outsourcing, by Type USD Million (2016-2021)
  • Table 122. Mexico Cell Banking Outsourcing, by Phase USD Million (2016-2021)
  • Table 123. Mexico Cell Banking Outsourcing, by Bank Storage USD Million (2016-2021)
  • Table 124. Mexico Cell Banking Outsourcing, by Cell Type USD Million (2016-2021)
  • Table 125. Cell Banking Outsourcing: by Type(USD/Units)
  • Table 126. Company Basic Information, Sales Area and Its Competitors
  • Table 127. Company Basic Information, Sales Area and Its Competitors
  • Table 128. Company Basic Information, Sales Area and Its Competitors
  • Table 129. Company Basic Information, Sales Area and Its Competitors
  • Table 130. Company Basic Information, Sales Area and Its Competitors
  • Table 131. Company Basic Information, Sales Area and Its Competitors
  • Table 132. Company Basic Information, Sales Area and Its Competitors
  • Table 133. Company Basic Information, Sales Area and Its Competitors
  • Table 134. Company Basic Information, Sales Area and Its Competitors
  • Table 135. Company Basic Information, Sales Area and Its Competitors
  • Table 136. Cell Banking Outsourcing: by Type(USD Million)
  • Table 137. Cell Banking Outsourcing Master Cell Banking , by Region USD Million (2022-2027)
  • Table 138. Cell Banking Outsourcing Working Cell Banking , by Region USD Million (2022-2027)
  • Table 139. Cell Banking Outsourcing Viral Cell Banking , by Region USD Million (2022-2027)
  • Table 140. Cell Banking Outsourcing: by Phase(USD Million)
  • Table 141. Cell Banking Outsourcing Preparation , by Region USD Million (2022-2027)
  • Table 142. Cell Banking Outsourcing Testing , by Region USD Million (2022-2027)
  • Table 143. Cell Banking Outsourcing Characterization , by Region USD Million (2022-2027)
  • Table 144. Cell Banking Outsourcing: by Bank Storage(USD Million)
  • Table 145. Cell Banking Outsourcing Master Cell Bank Storage , by Region USD Million (2022-2027)
  • Table 146. Cell Banking Outsourcing Working Cell Bank Storage , by Region USD Million (2022-2027)
  • Table 147. Cell Banking Outsourcing Cell Storage Stability Testing , by Region USD Million (2022-2027)
  • Table 148. Cell Banking Outsourcing: by Cell Type(USD Million)
  • Table 149. Cell Banking Outsourcing Stem Cell Banking , by Region USD Million (2022-2027)
  • Table 150. Cell Banking Outsourcing Non-Stem Cell Banking , by Region USD Million (2022-2027)
  • Table 151. South America Cell Banking Outsourcing, by Country USD Million (2022-2027)
  • Table 152. South America Cell Banking Outsourcing, by Type USD Million (2022-2027)
  • Table 153. South America Cell Banking Outsourcing, by Phase USD Million (2022-2027)
  • Table 154. South America Cell Banking Outsourcing, by Bank Storage USD Million (2022-2027)
  • Table 155. South America Cell Banking Outsourcing, by Cell Type USD Million (2022-2027)
  • Table 156. Brazil Cell Banking Outsourcing, by Type USD Million (2022-2027)
  • Table 157. Brazil Cell Banking Outsourcing, by Phase USD Million (2022-2027)
  • Table 158. Brazil Cell Banking Outsourcing, by Bank Storage USD Million (2022-2027)
  • Table 159. Brazil Cell Banking Outsourcing, by Cell Type USD Million (2022-2027)
  • Table 160. Argentina Cell Banking Outsourcing, by Type USD Million (2022-2027)
  • Table 161. Argentina Cell Banking Outsourcing, by Phase USD Million (2022-2027)
  • Table 162. Argentina Cell Banking Outsourcing, by Bank Storage USD Million (2022-2027)
  • Table 163. Argentina Cell Banking Outsourcing, by Cell Type USD Million (2022-2027)
  • Table 164. Rest of South America Cell Banking Outsourcing, by Type USD Million (2022-2027)
  • Table 165. Rest of South America Cell Banking Outsourcing, by Phase USD Million (2022-2027)
  • Table 166. Rest of South America Cell Banking Outsourcing, by Bank Storage USD Million (2022-2027)
  • Table 167. Rest of South America Cell Banking Outsourcing, by Cell Type USD Million (2022-2027)
  • Table 168. Asia Pacific Cell Banking Outsourcing, by Country USD Million (2022-2027)
  • Table 169. Asia Pacific Cell Banking Outsourcing, by Type USD Million (2022-2027)
  • Table 170. Asia Pacific Cell Banking Outsourcing, by Phase USD Million (2022-2027)
  • Table 171. Asia Pacific Cell Banking Outsourcing, by Bank Storage USD Million (2022-2027)
  • Table 172. Asia Pacific Cell Banking Outsourcing, by Cell Type USD Million (2022-2027)
  • Table 173. China Cell Banking Outsourcing, by Type USD Million (2022-2027)
  • Table 174. China Cell Banking Outsourcing, by Phase USD Million (2022-2027)
  • Table 175. China Cell Banking Outsourcing, by Bank Storage USD Million (2022-2027)
  • Table 176. China Cell Banking Outsourcing, by Cell Type USD Million (2022-2027)
  • Table 177. Japan Cell Banking Outsourcing, by Type USD Million (2022-2027)
  • Table 178. Japan Cell Banking Outsourcing, by Phase USD Million (2022-2027)
  • Table 179. Japan Cell Banking Outsourcing, by Bank Storage USD Million (2022-2027)
  • Table 180. Japan Cell Banking Outsourcing, by Cell Type USD Million (2022-2027)
  • Table 181. India Cell Banking Outsourcing, by Type USD Million (2022-2027)
  • Table 182. India Cell Banking Outsourcing, by Phase USD Million (2022-2027)
  • Table 183. India Cell Banking Outsourcing, by Bank Storage USD Million (2022-2027)
  • Table 184. India Cell Banking Outsourcing, by Cell Type USD Million (2022-2027)
  • Table 185. South Korea Cell Banking Outsourcing, by Type USD Million (2022-2027)
  • Table 186. South Korea Cell Banking Outsourcing, by Phase USD Million (2022-2027)
  • Table 187. South Korea Cell Banking Outsourcing, by Bank Storage USD Million (2022-2027)
  • Table 188. South Korea Cell Banking Outsourcing, by Cell Type USD Million (2022-2027)
  • Table 189. Taiwan Cell Banking Outsourcing, by Type USD Million (2022-2027)
  • Table 190. Taiwan Cell Banking Outsourcing, by Phase USD Million (2022-2027)
  • Table 191. Taiwan Cell Banking Outsourcing, by Bank Storage USD Million (2022-2027)
  • Table 192. Taiwan Cell Banking Outsourcing, by Cell Type USD Million (2022-2027)
  • Table 193. Australia Cell Banking Outsourcing, by Type USD Million (2022-2027)
  • Table 194. Australia Cell Banking Outsourcing, by Phase USD Million (2022-2027)
  • Table 195. Australia Cell Banking Outsourcing, by Bank Storage USD Million (2022-2027)
  • Table 196. Australia Cell Banking Outsourcing, by Cell Type USD Million (2022-2027)
  • Table 197. Rest of Asia-Pacific Cell Banking Outsourcing, by Type USD Million (2022-2027)
  • Table 198. Rest of Asia-Pacific Cell Banking Outsourcing, by Phase USD Million (2022-2027)
  • Table 199. Rest of Asia-Pacific Cell Banking Outsourcing, by Bank Storage USD Million (2022-2027)
  • Table 200. Rest of Asia-Pacific Cell Banking Outsourcing, by Cell Type USD Million (2022-2027)
  • Table 201. Europe Cell Banking Outsourcing, by Country USD Million (2022-2027)
  • Table 202. Europe Cell Banking Outsourcing, by Type USD Million (2022-2027)
  • Table 203. Europe Cell Banking Outsourcing, by Phase USD Million (2022-2027)
  • Table 204. Europe Cell Banking Outsourcing, by Bank Storage USD Million (2022-2027)
  • Table 205. Europe Cell Banking Outsourcing, by Cell Type USD Million (2022-2027)
  • Table 206. Germany Cell Banking Outsourcing, by Type USD Million (2022-2027)
  • Table 207. Germany Cell Banking Outsourcing, by Phase USD Million (2022-2027)
  • Table 208. Germany Cell Banking Outsourcing, by Bank Storage USD Million (2022-2027)
  • Table 209. Germany Cell Banking Outsourcing, by Cell Type USD Million (2022-2027)
  • Table 210. France Cell Banking Outsourcing, by Type USD Million (2022-2027)
  • Table 211. France Cell Banking Outsourcing, by Phase USD Million (2022-2027)
  • Table 212. France Cell Banking Outsourcing, by Bank Storage USD Million (2022-2027)
  • Table 213. France Cell Banking Outsourcing, by Cell Type USD Million (2022-2027)
  • Table 214. Italy Cell Banking Outsourcing, by Type USD Million (2022-2027)
  • Table 215. Italy Cell Banking Outsourcing, by Phase USD Million (2022-2027)
  • Table 216. Italy Cell Banking Outsourcing, by Bank Storage USD Million (2022-2027)
  • Table 217. Italy Cell Banking Outsourcing, by Cell Type USD Million (2022-2027)
  • Table 218. United Kingdom Cell Banking Outsourcing, by Type USD Million (2022-2027)
  • Table 219. United Kingdom Cell Banking Outsourcing, by Phase USD Million (2022-2027)
  • Table 220. United Kingdom Cell Banking Outsourcing, by Bank Storage USD Million (2022-2027)
  • Table 221. United Kingdom Cell Banking Outsourcing, by Cell Type USD Million (2022-2027)
  • Table 222. Netherlands Cell Banking Outsourcing, by Type USD Million (2022-2027)
  • Table 223. Netherlands Cell Banking Outsourcing, by Phase USD Million (2022-2027)
  • Table 224. Netherlands Cell Banking Outsourcing, by Bank Storage USD Million (2022-2027)
  • Table 225. Netherlands Cell Banking Outsourcing, by Cell Type USD Million (2022-2027)
  • Table 226. Rest of Europe Cell Banking Outsourcing, by Type USD Million (2022-2027)
  • Table 227. Rest of Europe Cell Banking Outsourcing, by Phase USD Million (2022-2027)
  • Table 228. Rest of Europe Cell Banking Outsourcing, by Bank Storage USD Million (2022-2027)
  • Table 229. Rest of Europe Cell Banking Outsourcing, by Cell Type USD Million (2022-2027)
  • Table 230. MEA Cell Banking Outsourcing, by Country USD Million (2022-2027)
  • Table 231. MEA Cell Banking Outsourcing, by Type USD Million (2022-2027)
  • Table 232. MEA Cell Banking Outsourcing, by Phase USD Million (2022-2027)
  • Table 233. MEA Cell Banking Outsourcing, by Bank Storage USD Million (2022-2027)
  • Table 234. MEA Cell Banking Outsourcing, by Cell Type USD Million (2022-2027)
  • Table 235. Middle East Cell Banking Outsourcing, by Type USD Million (2022-2027)
  • Table 236. Middle East Cell Banking Outsourcing, by Phase USD Million (2022-2027)
  • Table 237. Middle East Cell Banking Outsourcing, by Bank Storage USD Million (2022-2027)
  • Table 238. Middle East Cell Banking Outsourcing, by Cell Type USD Million (2022-2027)
  • Table 239. Africa Cell Banking Outsourcing, by Type USD Million (2022-2027)
  • Table 240. Africa Cell Banking Outsourcing, by Phase USD Million (2022-2027)
  • Table 241. Africa Cell Banking Outsourcing, by Bank Storage USD Million (2022-2027)
  • Table 242. Africa Cell Banking Outsourcing, by Cell Type USD Million (2022-2027)
  • Table 243. North America Cell Banking Outsourcing, by Country USD Million (2022-2027)
  • Table 244. North America Cell Banking Outsourcing, by Type USD Million (2022-2027)
  • Table 245. North America Cell Banking Outsourcing, by Phase USD Million (2022-2027)
  • Table 246. North America Cell Banking Outsourcing, by Bank Storage USD Million (2022-2027)
  • Table 247. North America Cell Banking Outsourcing, by Cell Type USD Million (2022-2027)
  • Table 248. United States Cell Banking Outsourcing, by Type USD Million (2022-2027)
  • Table 249. United States Cell Banking Outsourcing, by Phase USD Million (2022-2027)
  • Table 250. United States Cell Banking Outsourcing, by Bank Storage USD Million (2022-2027)
  • Table 251. United States Cell Banking Outsourcing, by Cell Type USD Million (2022-2027)
  • Table 252. Canada Cell Banking Outsourcing, by Type USD Million (2022-2027)
  • Table 253. Canada Cell Banking Outsourcing, by Phase USD Million (2022-2027)
  • Table 254. Canada Cell Banking Outsourcing, by Bank Storage USD Million (2022-2027)
  • Table 255. Canada Cell Banking Outsourcing, by Cell Type USD Million (2022-2027)
  • Table 256. Mexico Cell Banking Outsourcing, by Type USD Million (2022-2027)
  • Table 257. Mexico Cell Banking Outsourcing, by Phase USD Million (2022-2027)
  • Table 258. Mexico Cell Banking Outsourcing, by Bank Storage USD Million (2022-2027)
  • Table 259. Mexico Cell Banking Outsourcing, by Cell Type USD Million (2022-2027)
  • Table 260. Cell Banking Outsourcing: by Type(USD/Units)
  • Table 261. Research Programs/Design for This Report
  • Table 262. Key Data Information from Secondary Sources
  • Table 263. Key Data Information from Primary Sources
List of Figures
  • Figure 1. Porters Five Forces
  • Figure 2. Supply/Value Chain
  • Figure 3. PESTEL analysis
  • Figure 4. Global Cell Banking Outsourcing: by Type USD Million (2016-2021)
  • Figure 5. Global Cell Banking Outsourcing: by Phase USD Million (2016-2021)
  • Figure 6. Global Cell Banking Outsourcing: by Bank Storage USD Million (2016-2021)
  • Figure 7. Global Cell Banking Outsourcing: by Cell Type USD Million (2016-2021)
  • Figure 8. South America Cell Banking Outsourcing Share (%), by Country
  • Figure 9. Asia Pacific Cell Banking Outsourcing Share (%), by Country
  • Figure 10. Europe Cell Banking Outsourcing Share (%), by Country
  • Figure 11. MEA Cell Banking Outsourcing Share (%), by Country
  • Figure 12. North America Cell Banking Outsourcing Share (%), by Country
  • Figure 13. Global Cell Banking Outsourcing: by Type USD/Units (2016-2021)
  • Figure 14. Global Cell Banking Outsourcing share by Players 2021 (%)
  • Figure 15. Global Cell Banking Outsourcing share by Players (Top 3) 2021(%)
  • Figure 16. Global Cell Banking Outsourcing share by Players (Top 5) 2021(%)
  • Figure 17. BCG Matrix for key Companies
  • Figure 18. BioReliance (United States) Revenue, Net Income and Gross profit
  • Figure 19. BioReliance (United States) Revenue: by Geography 2021
  • Figure 20. Global Stem Inc (United States) Revenue, Net Income and Gross profit
  • Figure 21. Global Stem Inc (United States) Revenue: by Geography 2021
  • Figure 22. BSL Disservice (United States) Revenue, Net Income and Gross profit
  • Figure 23. BSL Disservice (United States) Revenue: by Geography 2021
  • Figure 24. Clean cells (France) Revenue, Net Income and Gross profit
  • Figure 25. Clean cells (France) Revenue: by Geography 2021
  • Figure 26. Charles River Laboratories Lonza (United States) Revenue, Net Income and Gross profit
  • Figure 27. Charles River Laboratories Lonza (United States) Revenue: by Geography 2021
  • Figure 28. Toxikon Corporation (United States) Revenue, Net Income and Gross profit
  • Figure 29. Toxikon Corporation (United States) Revenue: by Geography 2021
  • Figure 30. Cryobanks International (India) Revenue, Net Income and Gross profit
  • Figure 31. Cryobanks International (India) Revenue: by Geography 2021
  • Figure 32. Wuxi Apptec (China) Revenue, Net Income and Gross profit
  • Figure 33. Wuxi Apptec (China) Revenue: by Geography 2021
  • Figure 34. Reliance Life Sciences (India) Revenue, Net Income and Gross profit
  • Figure 35. Reliance Life Sciences (India) Revenue: by Geography 2021
  • Figure 36. BioOutsource (India) Revenue, Net Income and Gross profit
  • Figure 37. BioOutsource (India) Revenue: by Geography 2021
  • Figure 38. Global Cell Banking Outsourcing: by Type USD Million (2022-2027)
  • Figure 39. Global Cell Banking Outsourcing: by Phase USD Million (2022-2027)
  • Figure 40. Global Cell Banking Outsourcing: by Bank Storage USD Million (2022-2027)
  • Figure 41. Global Cell Banking Outsourcing: by Cell Type USD Million (2022-2027)
  • Figure 42. South America Cell Banking Outsourcing Share (%), by Country
  • Figure 43. Asia Pacific Cell Banking Outsourcing Share (%), by Country
  • Figure 44. Europe Cell Banking Outsourcing Share (%), by Country
  • Figure 45. MEA Cell Banking Outsourcing Share (%), by Country
  • Figure 46. North America Cell Banking Outsourcing Share (%), by Country
  • Figure 47. Global Cell Banking Outsourcing: by Type USD/Units (2022-2027)
Some of the key companies/manufacturers profiled in the report
  • BioReliance (United States)
  • Global Stem Inc (United States)
  • BSL Disservice (United States)
  • Clean cells (France)
  • Charles River Laboratories Lonza (United States)
  • Toxikon Corporation (United States)
  • Cryobanks International (India)
  • Wuxi Apptec (China)
  • Reliance Life Sciences (India)
  • BioOutsource (India)
Additional players considered in the study are as follows:
CordLife (Singapore) , PX’Therapeutics SA (France) , SGS Life Sciences (India)
Select License Type
Sample Report Enquiry Before Buy Request Discount

Speak with Analyst

Want to find out more about this report?

Get Free Consultation